Based on current trading volume trends, the IBRX stock price forecast points to consolidation above $5. A great starting point for your ImmunityBio research is our analysis highlighting 2 key rewards and 2 important warning signs that could impact your investment decision. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Institutional research upgrades have lifted the IBRX stock price forecast outlook. One major brokerage set a 12-month price target at $7.20, citing differentiated oncology assets and competitive market positioning.
